Letters sent to healthcare professionals in December 2015

In December 2015, a letter was sent to healthcare professionals regarding Reminyl (galantamine hydrobromide).

From:
Medicines and Healthcare products Regulatory Agency
Published
21 January 2016
Therapeutic area:
Dermatology, Neurology

In December 2015, a letter was sent to healthcare professionals for:

  • galantamine hydrobromide (Reminyl): risk of serious skin reactions

Updates to this page

Published 21 January 2016